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Intravenous patient-controlled analgesia (IVPCA)
is a widely used postoperative analgesic method.
Many studies have shown that patient-controlled
epidural analgesia offers better analgesia, superior
outcomes and fewer side effects than IVPCA.1–3
However, because of the satisfactory analgesic effect
and the feasible and reliable route of drug admin-
istration, IVPCA is still a popular postoperative
analgesic choice. Many factors can affect the total
analgesic requirements during the course of IVPCA,
including age, weight, sex and pain upon move-
ment. Previous studies found that age and sex have
more influence on postoperative IVPCA morphine
consumption, while the effect of weight remains
controversial.4–6 Dose adjustments of many drugs
tare based on weight, but the influence of weigh
on IVPCA demand has not been established.
This retrospective study evaluated the correlation
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between patient characteristics and total mor-
phine consumption during a 3-day course of post-
operative IVPCA. A stratified analysis according
to surgical site, age, and body mass index (BMI)
subgroups was also conducted to identify which
factors have a significant association with post-
operative IVPCA requirement.
Methods
This retrospective study was conducted based on
data from patients who were treated in our hos-
pital between January 2002 and December 2003.
All patients were aged between 15 and 85 years,
had clear consciousness, received surgical proce-
dures with general anesthesia, and used postop-
erative IVPCA. All patients used IVPCA for at
least 3 days and then switched to oral analgesia
based on their individual condition. The exclu-
sion criteria were: receiving postoperative venti-
lator support or ICU care for more than 6 hours;
unstable postoperative condition or major compli-
cations and discontinuing IVPCA for any reason.
General anesthesia was inducted with fentanyl
(3–5 μg/kg), thiopental (4–6 mg/kg) and rocuro-
nium 0.8 mg/kg. Anesthesia was maintained with
rocuronium–desflurane in 40–60% oxygen/air
mixture. Demographic data were collected includ-
ing age, sex, weight, height and BMI. Operation
type and surgical sites were also recorded. All of
the study population received postoperative IVPCA
with the same type of infusion device (Abbott Pain
Manager II; Abbott Laboratories, North Chicago,
IL, USA) and were instructed on how to use the
apparatus before surgery.
After transfer to the post-anesthetic care unit,
the patient was connected to the PCA infusion
device via an intravenous line. The PCA solution
was prepared as 1mg/mL morphine. The apparatus
was set to deliver 1–1.5 mL solution on demand
with a 5-minute lockout interval. After set-up of
the PCA device, a loading dose of 0.05 mg/kg was
given, and cumulative dose recording was started.
All patients were visited by the PCA team staff in
the morning and afternoon of each day and,
whenever clinically necessary, 24 hours a day. Pain
intensity was assessed using verbal pain score
(where 1 = no pain and 10 = most intense pain
imaginable) during these visits. The PCA team
tstaff recorded the total IVPCA consumption a
the end of the 3rd day.
Statistical analysis
Data for continuous demographic variables
and total IVPCA morphine consumption were
expressed as mean ± standard deviation. Because
tdifferent surgical locations could have distinc
influences on IVPCA requirements, operations
were divided into the following five categories
according to the surgical site: spine, lower abdo-
men, upper abdomen, gynecologic, and extremi-
ties. One-way analysis of variance (ANOVA) was
used to correlate age, weight, height, and BMI
ywith total IVPCA consumption during the 3-da
postoperative course among the different sur-
gical subgroups. If variances were not compara-
ble between different surgical subgroups, Welch’s
variance-weighted ANOVA was run instead of the
traditional ANOVA. A p value less than 0.05 was
considered significant. When significant differences
among surgical subgroups were found, cpost ho
analysis was conducted with Bonferroni’s cor-
rection. Proportions of gender and procedures
involving malignant disease among surgical sub-
groups were compared using χ2 test. Pearson’s
product moment correlation coefficients were cal-
culated to determine the correlation between total
cIVPCA requirements and continuous demographi
variables. Subgroup analyses were also conducted
according to the surgical site.
Stepwise linear regression analyses were con-
ducted to select significant variables which could
predict total IVPCA consumption. The entry crite-
ria was significance of the regression coefficients
< 0.05, and the exit criteria was significance > 0.10.
The variables used for model selection were weight,
rheight, age, gender (coded as 0 for male and 1 fo
female), procedures involving malignant disease
(coded as 0 for non-malignant and 1 for malig-
nant), and surgical sites (with four dummy vari-
ables and using gynecologic operations as the
ffFactors a ecting PCA requirements
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reference group). BMI was excluded from the
analysis due to its strong correlation with weight
and height. Due to concern regarding whether
patients with different characteristics had dis-
tinct IVPCA requirements, we dichotomized the
original data according to patient age (≥ 65 years
old vs. < 65 years old) and BMI (≥ 24 vs. < 24).7 In
order to determine whether the influential factors
of total IVPCA consumption were identical in the
different subgroups, stratified analyses were also
performed. Standardized regression coefficients
were used to compare the strength of association
among different factors. Multiple correlation co-
efficients (R) and adjusted R2 values were also
calculated for the various models of all sub-
groups. All statistical analyses were performed with
SPSS version 14.0 (SPSS Inc., Chicago, IL, USA).
Results
A total of 1308 patients (646 men, 662 women)
were included in the analysis. The mean verbal
pain scores on the 1st, 2nd and 3rd days were
2.4±1.6, 1.7±1.4 and 1.2±0.9, respectively. Table
1 lists the demographic data and total IVPCA
consumption during the 3-day course among
different surgical sites. One-way ANOVA and χ2
test revealed significant differences in age, weight,
height, BMI, and total IVPCA requirements among
the different surgical sites (all p < 0.001). There
were also significant differences in the proportions
of sex and procedures involving malignant dis-
ease among various surgical sites (all p < 0.001).
After post hoc tanalyses, the results showed tha
gynecologic patients were the youngest and con-
sumed the least morphine (all p < 0.001, com-
ypared with the other surgical subgroups). The
also had the shortest body height (p < 0.001 to
p = y0.03). Patients in the upper abdominal surger
subgroup required the most morphine (p < 0.001
to p=0.04). Patients in the subgroup receiving sur-
gery of ythe spine or extremities had a significantl
higher BMI value (all p < 0.001, compared with
rthe other three subgroups) and were also heavie
than patients in the other subgroups (p < 0.001
to p = 0.04).
Table 2 lists the Pearson correlation coefficients
(r) with p values between total IVPCA morphine
requirements and demographic data in the dif-
ferent surgical site subgroups. Weight was posi-
tively correlated with total IVPCA demand in all
surgical subgroups (all p < 0.001). The correla-
Ation coefficients between weight and total IVPC
demand were 0.347 among all operations and
ranged from 0.326 to 0.421 in different sub-
groups. Age was negatively correlated with total
IVPCA consumption in all surgical subgroups.
However, this correlation was not significant in
the gynecologic and upper abdominal surgical
site subgroups (p = 0.511 and 0.349, respectively).
ABMI was significantly correlated with total IVPC
Table 1. Demographic data and total patient-controlled analgesia (PCA) requirements in patients with operations at 
different sites
Surgical site Extremities Spine Upper abdomen Lower abdomen Gynecologic p Overall
Number 356 385 191 174 202 – 1308
Sex (M:F) 208:148 213:172 127:64 98:76 0:202 < 0.001 646:662
Malignancy* 8 6 50 133 79 < 0.001 276
Weight (kg) 65.78 ± 12.27 64.59 ± 11.42 61.63 ± 11.44 58.86 ± 10.77 57.30 ± 10.61 < 0.001 62.58 ± 11.86
Height (cm)† 160.92 ± 9.54 160.05 ± 8.85 162.23 ± 8.08 159.39 ± 8.92 156.75 ± 6.19 < 0.001 160.01 ± 8.72
BMI 25.41 ± 4.29 25.18 ± 3.76 23.38 ± 3.77 23.14 ± 3.68 23.32 ± 4.10 < 0.001 24.42 ± 4.07
Age (yr)† 60.59 ± 18.77 63.18 ± 17.40 63.54 ± 16.15 67.92 ± 13.80 47.38 ± 13.76 < 0.001 60.73 ± 17.71
Total dose (mg)‡ 60.88 ± 23.96 63.33 ± 24.67 76.21 ± 23.90 69.14 ± 23.71 49.05 ± 19.35 < 0.001 63.07 ± 24.73
*Surgical procedures for the treatment of malignant diseases; †Levene’s test showed unequal variance so Welch’s variance-weighted analysis of variance
(ANOVA) was therefore used instead of the traditional ANOVA; ‡total intravenous PCA morphine consumption during the 3-day postoperative PCA course.
BMI = body mass index.
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requirements except in the lower abdominal sur-
gery subgroup (p=0.079). Height was significantly
associated with total IVPCA demand except in
the gynecologic surgery subgroup (p = 0.075).
Table 3 shows the results of stepwise linear
regression analyses conducted to select potential
factors associated with total IVPCA requirements
with variables including weight, age, gender, height,
surgical site and procedures involving malignancy.
In the overall analysis, surgical site, weight, age and
tprocedures involving malignancy were the mos
Asignificant factors associated with total IVPC
requirements. The R and adjusted R2 fvalues o
this model were 0.510 and 0.256, respectively.
rTable 4 shows the results of separate analyses fo
the different surgical site subgroups. Weight was
Table 2. Correlation between total patient-controlled analgesia (PCA) requirement and weight,
height, body mass index (BMI) and age by surgical site
Surgical site Weight Height BMI Age
Overall*
r 0.347 0.252 0.231 −0.067
p < 0.001 < 0.001 < 0.001 0.013
Spine
r 0.386 0.112 0.374 −0.195
p < 0.001 0.028 < 0.001 < 0.001
Lower abdomen
r 0.326 0.338 0.134 −0.292
p < 0.001 < 0.001 0.079 < 0.001
Upper abdomen
r 0.329 0.254 0.223 −0.068
p < 0.001 < 0.001 0.002 0.349
Gynecologic
r 0.421 0.126 0.390 −0.046
p < 0.001 0.075 < 0.001 0.511
Lower extremity
r 0.346 0.262 0.197 −0.198
p < 0.001 < 0.001 < 0.001 < 0.001
*Overall means all of the patients included in the study.







Surgical site 0.510 0.256
Upper abdomen vs. gynecologic 28.99 2.25 < 0.001 0.41
Lower abdomen vs. gynecologic 23.05 2.43 0.32
Spine vs. gynecologic 14.80 2.08 0.27
Extremities vs. gynecologic 10.53 2.08 0.19
Weight (per 10 kg) 7.88 0.52 0.38
Age (per 10 yr) −2.87 0.36 −0.21
Malignancy vs. non-malignancy* 4.560 1.88 0.015 0.08
Constant† 15.73 3.75
*Malignancy means surgical procedures for the treatment of malignant disease; †gynecologic surgeries were used as the reference
group for other surgical sites. SE = standard error.
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the most common factor that was significantly
associated with total IVPCA requirement in all
of the surgical subgroup analyses. Age was also 
a significant factor except in the upper abdomi-
nal surgery subgroup. Gender was significantly
associated with analgesia requirement only in the
lower abdominal operations. Procedures involv-
ing malignancy was a significant factor only 
in patients who underwent gynecologic surgery.
The multiple correlation coefficients of selected
models in subgroup analyses ranged from 0.329
to 0.511.
Tables 5 and 6 list the results of stepwise regres-
sion analyses among different age and BMI sub-
Agroups. The determinative factors of total IVPC
requirements in the different BMI subgroups were
identical. The selected factors were surgical site,
weight and age. However, the selected variables
twere not consistently predictive in the differen
age groups. For elderly patients (age ≥ 65 years),
Table 4. Model selection with multiple correlation coefficients (R) by different surgical sites






Spine Weight 8.35 1.00 < 0.001 0.39 0.433 0.183
Age −2.77 0.65 < 0.001 −0.20
Lower abdomen Weight 6.23 1.57 < 0.001 0.28 0.481 0.218
Age −5.76 1.17 < 0.001 −0.33
Gender −8.69 3.44 0.012 −0.18
Upper abdomen Weight 6.88 1.44 < 0.001 0.33 0.329 0.104
Gynecology Weight 8.35 1.14 < 0.001 0.46 0.511 0.250
Malignancy* 10.31 2.42 < 0.001 0.26
Age −2.04 0.88 0.021 −0.15
Extremities Weight 7.38 0.95 < 0.001 0.38 0.423 0.174
Age −3.14 0.62 < 0.001 −0.25
*Malignancy means the group with malignant disease compared to the group without malignant disease. The units for weight and age
are 10 kg and 10 years, respectively. SE = standard error.
Table 5. Model selection* with multiple correlation coefficients (R) by different body mass index (BMI)
groups






BMI < 24 (n = 620) Surgical site* 0.496 0.239
Upper abdomen 28.01 2.72 < 0.001 0.47
Lower abdomen 24.75 2.85 < 0.001 0.39
Spine 9.57 2.55 < 0.001 0.18
Extremities 8.58 2.55 0.001 0.15
Weight (per 10 kg) 7.93 1.07 < 0.001 0.27
Age (per 10 yr) −2.09 0.44 < 0.001 −0.18
BMI ≥ 24 (n = 688) Surgical site* 0.470 0.214
Upper abdomen 28.96 3.745 < 0.001 0.367
Lower abdomen 24.97 3.835 < 0.001 0.31
Spine 16.20 3.116 < 0.001 0.31
Extremities 10.44 3.158 0.001 0.19
Weight (per 10 kg) 6.93 0.88 < 0.001 0.27
Age (per 10 yr) −4.23 0.61 < 0.001 −0.25
*Gynecologic surgery served as the reference subgroup for the other surgical site subgroups. SE = standard error.
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surgical site, weight and age were all significant
predictors of total IVPCA requirement. For patients
younger than 65 years, however, surgical site,
weight and procedures involving malignancy were
the predictive factors of total IVPCA consump-
tion. The correlation coefficients of the selected
models in these stratified analyses ranged from
0.470 to 0.541.
Discussion
This study found that the demographic charac-
teristics and the site of surgery were significant
predictors of IVPCA consumption. Patients who
received upper abdominal operation consumed
the most morphine. This finding may be attribut-
able to the more extensive and traumatic nature
of abdominal surgery compared to surgery at other
sites, and the more severe postoperative pain
associated with such procedures. There findings
suggest that a greater volume of IVPCA solution
should be prepared for patients receiving upper
abdominal surgery. In this study, patients who
underwent gynecologic surgery required the least
quantity of IVPCA. They were also younger than
patients in the other groups. These findings sug-
gest that gynecologic operations are not as trau-
matic as other types of surgeries and perhaps also
that women may require less morphine per se f. I
the study population includes a significant propor-
tion of gynecologic patients, inferences about the
geffects of other variables may be biased. Separatin
the gynecologic procedures from other operations
in the analysis is necessary to identify such an
effect. In this study, patients who underwent sur-
tgery of the spine or extremities had the greates
BMI. This finding suggests that obesity is associ-
ated with orthopedic disorders that require sur-
gical intervention, which is compatible with the
findings of previous studies.8–10
The purpose of this study was to explore
 the correlation between 3-day IVPCA morphine
consumption and the characteristics of patients
undergoing various types of surgery. Weight, age,
surgical sites and procedures involving malig-
nancy were all included in the overall analysis.
One-way ANOVA revealed significant differences
in IVPCA consumption in the various surgical
subgroups. Further analysis based on surgical site
tsubgroups was therefore performed. As overweigh
and aging may also affect IVPCA consumption,
Table 6. Model selection* with multiple correlation coefficients (R) by different age groups






Age < 65 yr (n = 626) Surgical site* 0.541 0.285
Upper abdomen 26.74 2.96 < 0.001 0.35
Lower abdomen 23.83 3.43 < 0.001 0.28
Spine 16.93 2.70 < 0.001 0.28
Extremities 13.44 2.58 < 0.001 0.23
Weight (per 10 kg) 7.52 0.73 < 0.001 0.36
Malignancy† 6.72 2.53 0.008 0.11
Age ≥ 65 yr (n = 682) Surgical site* 0.502 0.246
Upper abdomen 28.74 4.25 < 0.001 0.45
Lower abdomen 22.37 4.26 < 0.001 0.35
Spine 11.389 4.00 0.005 0.23
Extremities 6.88 4.12 0.095 0.13
Weight (per 10 kg) 7.03 0.72 < 0.001 0.34
Age (per 10 yr) −8.61 1.48 < 0.001 −0.20
*Gynecologic surgery served as the reference subgroup for the other surgical site subgroups; †malignancy means the group with 
malignant disease compared to the group without malignant disease. SE = standard error.
we also dichotomized the data according to BMI
and age. In the subgroup analyses, weight was
the most common factor related to total IVPCA
requirement. Previous studies have also shown
a significant but very weak correlation between
weight and IVPCA consumption.5,11 The effect of
surgical site was significant in both the overall
and subgroup analyses. A retrospective study in
Chinese used weight-based PCA morphine con-
sumption to compare means among different
factors and found that patients undergoing dif-
ferent operations required different amounts of
morphine.12 These findings are compatible with
those of this study.
Chia et al analyzed 2298 Chinese patients
and found that gender was a significant factor
associated with IVPCA requirement.4 In the pre-
sent study, gender was not a significant factor
except in patients with lower abdominal surgery.
Several possible reasons might explain this dis-
crepancy. First, in Chia et al’s study, 63% of the
patients were female, but they did not separate
gynecologic from abdominal procedures in the
analysis. In the present study, patients undergo-
ing upper abdominal surgery required the most
morphine and those who underwent gynecologic
procedures required the least. If a significant pro-
portion of female patients in the sample have
gynecologic procedures, the analysis of the asso-
ciation with surgical site may be affected. In this
study, when surgical site was excluded from the
stepwise regression analysis, gender was selected
as a significant factor affecting IVPCA consump-
tion. However, its adjusted R2 value in this model
was only 0.164, which was far less than the
adjusted R2 value of the original model (0.256).
Moreover, male patients required 24–43% more
IVPCA morphine and had 21% higher pain level
on movement than females. One possible expla-
nation for these findings is that males may have
experienced more severe pain due to having under-
gone more traumatic procedures and, therefore,
consumed more morphine. Adjustment for the
effect of surgical site is needed before evaluation
of the effects of other variables. Gender may impact
IVPCA consumption of opioids, but the direction
and magnitude of these differences also depend
on many interacting variables.13,14 In this study,
gthe effect of gender was significant only amon
patients who received lower abdominal opera-
tions. Some previous studies which assessed the
influence of demographic factors on PCA require-
ments also had similar findings.15–17
AAge was negatively correlated with IVPC
gmorphine consumption in this study. This findin
is in agreement with most previous studies.5,15–17
Pharmacokinetic and pharmacodynamic correlates
of aging may at least partly explain this change.
fAs the aging process continues, the volume o
distribution and clearance of morphine decrease
progressively. Plasma albumin also decreases to
a similar extent and it results in a greater unbound
fraction of drug. These pharmacokinetic factors
lead to higher plasma drug levels and prolong the
duration of action in the elderly. Therefore, mor-
phine consumption decreases as age increases.18–20
However, in this study, the age effect was not sig-
nificant among non-elderly (< 65 years old) and
in patients undergoing upper abdominal surgery.
One possible explanation of this lack of correla-
ytion in non-elderly patients is that the capacit
of morphine metabolism has not yet changed to
ra significant extent. For patients undergoing uppe
abdominal surgery, weight was the only signifi-
cant correlate of morphine consumption, with an
adjusted R2 tvalue of only 0.104. This means tha
the selected model could explain only about 10%
of the total variation in morphine consumption
among these patients. Further study to determine
the correlates of the unexplained proportion awaits
further investigation.
tBMI is a widely used tool for the measuremen
tof obesity. In this study, however, BMI was no
used as a candidate for stepwise model selection
tdue to its high correlation with weight and heigh
and possible collinearity in the selected model.
ABecause body fat content may influence IVPC
requirements, we dichotomized the data accord-
ing to BMI (< 24 and ≥ 24) and conducted strati-
fied analyses. This cut-off point was selected based
on the study of Pan et al among Taiwanese.7
tAlthough the regression coefficients were differen
K.Y. Chang, et al
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in these two models, BMI status did not change
the determinative factors of IVPCA consumption.
Surgical sites, weight and age were all common
factors regardless of BMI status.
Although several determinative factors of total
IVPCA requirements were elucidated in this study,
the adjusted R2 values of the models ranged only
between 0.104 and 0.285. Despite the significant
correlation, the obtained factors were still too
weakly correlated to predict IVPCA consump-
tion accurately. Other variables which were not
included in this study may have more influence
on IVPCA requirements. Further study including
more explanatory variables is needed.
In conclusion, weight, age, surgical sites and
procedures involving malignancy were strongly
associated with total IVPCA requirements in the
overall analysis. Weight was the most common
and positive correlate of total IVPCA require-
ment. Age was negatively correlated with IVPCA
consumption, but this effect was not significant
among patients younger than 65 years. Gender
and height were not determinative factors of
cumulative IVPCA requirement. BMI status did not
affect the determinative factors of total IVPCA
requirement.
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